Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3

被引:153
作者
Barbui, Tiziano [1 ]
Carobbio, Alessandra
Finazzi, Guido
Vannucchi, Alessandro M. [2 ,3 ]
Barosi, Giovanni [4 ,5 ]
Antonioli, Elisabetta [2 ,3 ]
Guglielmelli, Paola [2 ,3 ]
Pancrazzi, Alessandro [2 ,3 ]
Salmoiraghi, Silvia
Zilio, Pio [6 ]
Ottomano, Cosimo [6 ]
Marchioli, Roberto [7 ]
Cuccovillo, Ivan [8 ]
Bottazzi, Barbara [8 ]
Mantovani, Alberto [8 ,9 ]
Rambaldi, Alessandro
机构
[1] Osped Riuniti Bergamo, Div Ematol, Dept Hematol, I-24128 Bergamo, Italy
[2] Univ Florence, Dipartimento Area Crit, Unita Funz Ematol, Florence, Italy
[3] Ist Toscano Tumori, Florence, Italy
[4] Policlin S Matteo Fdn, IRCCS, Clin Epidemiol Unit, Pavia, Italy
[5] Policlin S Matteo Fdn, IRCCS, Ctr Study Myelofibrosis, Pavia, Italy
[6] Osped Riuniti Bergamo, Clin Chem Lab, I-24128 Bergamo, Italy
[7] Consorzio Mario Negri Sud, Lab Clin Epidemiol Cardiovasc Dis, Santa Maria Imbaro, CH, Italy
[8] IRCCS, Ist Clin Humanitas, Lab Immunol & Inflammat, Milan, Italy
[9] Univ Milan, Dipartimento Med Traslaz, Milan, Italy
来源
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2011年 / 96卷 / 02期
关键词
essential thrombocythemia; polycythemia vera; C-reactive protein; pentraxin; 3; ACUTE MYOCARDIAL-INFARCTION; MYELOPROLIFERATIVE DISORDERS; PTX3; RISK; LEUKOCYTOSIS; MUTATION; DISEASE;
D O I
10.3324/haematol.2010.031070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We tested the hypothesis that levels of pentraxin high sensitivity C-reactive protein and pentraxin 3 might be correlated with cardiovascular complications in patients with essential thrombocythemia and polycythemia vera. High sensitivity C-reactive protein and pentraxin 3 were measured in 244 consecutive essential thrombocythemia and polycythemia vera patients in whom, after a median follow up of 5.3 years (range 0-24), 68 cardiovascular events were diagnosed. The highest C-reactive protein tertile was compared with the lowest (> 3 vs. < 1 mg/L) and correlated with age (P=0.001), phenotype (polycythemia vera vs. essential thrombocythemia, P=0.006), cardiovascular risk factors (P=0.012) and JAK2V617F allele burden greater than 50% (P=0.003). Major thrombosis rate was higher in the highest C-reactive protein tertile (P=0.01) and lower at the highest pentraxin 3 levels (P=0.045). These associations remained significant in multivariate analyses and indicate that blood levels of high sensitivity C-reactive protein and petraxin 3 independently and in opposite ways modulate the intrinsic risk of cardiovascular events in patients with myeloproliferative disorders.
引用
收藏
页码:315 / 318
页数:4
相关论文
共 19 条
[1]   Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor? [J].
Barbui, Tiziano ;
Carobbio, Alessandra ;
Rambaldi, Alessandro ;
Finazzi, Guido .
BLOOD, 2009, 114 (04) :759-763
[2]   C-reactive protein and cardiovascular risk: more fuel to the fire [J].
Boekholdt, S. Matthijs ;
Kastelein, John J. P. .
LANCET, 2010, 375 (9709) :95-96
[3]   Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia [J].
Carobbio, Alessandra ;
Finazzi, Guido ;
Antonioli, Elisabetta ;
Guglielmelli, Paola ;
Vannucchi, Alessandro M. ;
Delaini, Federica ;
Guerini, Vittoria ;
Ruggeri, Marco ;
Rodeghiero, Francesco ;
Rambaldi, Alessandro ;
Barbui, Tiziano .
BLOOD, 2008, 112 (08) :3135-3137
[4]   Leukocytosis and risk stratification assessment in essential thrombocythemia [J].
Carobbio, Alessandra ;
Antonioli, Elisabetta ;
Guglielmelli, Paola ;
Vannucchi, Alessandro M. ;
Delaini, Federica ;
Guerini, Vittoria ;
Finazzi, Guido ;
Rambaldi, Alessandro ;
Barbui, Tiziano .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) :2732-2736
[5]   Regulation of leukocyte recruitment by the long pentraxin PTX3 [J].
Deban, Livija ;
Russo, Remo Castro ;
Sironi, Marina ;
Moalli, Federica ;
Scanziani, Margherita ;
Zambelli, Vanessa ;
Cuccovillo, Ivan ;
Bastone, Antonio ;
Gobbi, Marco ;
Valentino, Sonia ;
Doni, Andrea ;
Garlanda, Cecilia ;
Danese, Silvio ;
Salvatori, Giovanni ;
Sassano, Marica ;
Evangelista, Virgilio ;
Rossi, Barbara ;
Zenaro, Elena ;
Constantin, Gabriela ;
Laudanna, Carlo ;
Bottazzi, Barbara ;
Mantovani, Alberto .
NATURE IMMUNOLOGY, 2010, 11 (04) :328-U74
[6]   C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis [J].
Kaptoge, Stephen ;
Di Angelantonio, Emanuele ;
Lowe, Gordon ;
Pepys, Mark B. ;
Thompson, Simon G. ;
Collins, Rory ;
Danesh, John ;
Tipping, R. W. ;
Ford, C. E. ;
Pressel, S. L. ;
Walldius, G. ;
Jungner, I. ;
Folsom, A. R. ;
Chambless, L. ;
Ballantyne, C. M. ;
Panagiotakos, D. ;
Pitsavos, C. ;
Chrysohoou, C. ;
Stefanadis, C. ;
Knuiman, M. W. ;
Goldbourt, U. ;
Benderly, M. ;
Tanne, D. ;
Whincup, P. ;
Wannamethee, S. G. ;
Morris, R. W. ;
Kiechl, S. ;
Willeit, J. ;
Mayr, A. ;
Schett, G. ;
Wald, N. ;
Ebrahim, S. ;
Lawlor, D. ;
Yarnell, J. ;
Gallacher, J. ;
Casiglia, E. ;
Tikhonoff, V. ;
Nietert, P. J. ;
Sutherland, S. E. ;
Bachman, D. L. ;
Keil, J. E. ;
Cushman, M. ;
Psaty, B. M. ;
Tracy, R. ;
Tybjaerg-Hansen, A. ;
Nordestgaard, B. G. ;
Zacho, J. ;
Frikke-Schmidt, R. ;
Giampaoli, S. ;
Palmieri, L. .
LANCET, 2010, 375 (9709) :132-140
[7]   Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 [J].
Kralovics, R ;
Teo, SS ;
Buser, AS ;
Brutsche, M ;
Tiedt, R ;
Tichelli, A ;
Passamonti, F ;
Pietra, D ;
Cazzola, M ;
Skoda, RC .
BLOOD, 2005, 106 (10) :3374-3376
[8]   Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction [J].
Latini, R ;
Maggioni, AP ;
Peri, G ;
Gonzini, L ;
Lucci, D ;
Mocarelli, P ;
Vago, L ;
Pasqualini, F ;
Signorini, S ;
Soldateschi, D ;
Tarli, L ;
Schweiger, C ;
Fresco, C ;
Cecere, R ;
Tognoni, G ;
Mantovani, A .
CIRCULATION, 2004, 110 (16) :2349-2354
[9]   The role of selectins in inflammation and disease [J].
Ley, K .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (06) :263-268
[10]   Vascular and neoplastic risk in a large cohort of patients with polycythemia vera [J].
Marchioli, R ;
Finazzi, G ;
Landolfi, R ;
Kutti, J ;
Gisslinger, H ;
Patrono, C ;
Marilus, R ;
Villegas, A ;
Tognoni, G ;
Barbui, T .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2224-2232